Orbus Therapeutics

Aptos, United States · Founded 2012 · $71.0M raised

Headquarters
Aptos
Founded
2012
Total Funding
$71.0M
Last Round
$38.5M Extension RoundOct 2020
Rounds
2

About

Orbus Therapeutics develops and commercializes treatments for rare diseases that have few or no effective therapies. The company is focused on improving outcomes for underserved patients facing life-threatening or significantly life-altering conditions. Its current work includes developing and commercializing eflornithine in North America and Europe for patients affected by rare diseases.

Summary

Orbus Therapeutics is a Biotech company based in Aptos, United States, founded in 2012. It has raised $71.0M in total across 2 rounds, most recently a $38.5M Extension Round round in Oct 2020. Investors include Agent Capital.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A ExtensionOct 2020
$38.5M

Sign up to see all 2 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orbus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/orbus-therapeutics"><img src="https://indexed.vc/api/badge/company/orbus-therapeutics" alt="Orbus Therapeutics on Indexed.vc" width="260" height="76" /></a>